about
Female premenopausal fracture risk is associated with gc phenotype.Soluble CD163.CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein.Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study.Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.Alcoholic Hepatitis Markedly Decreases the Capacity for Urea SynthesisTargeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.Anti-inflammatory liposomes have no impact on liver regeneration in ratsHigh mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective studyAnti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats.Hemoglobin and heme scavenger receptors.Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity.Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor-alpha.Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients.Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system.Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).A multi-biomarker follow-up study of patients with multiple sclerosis.Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasmaAntibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory.The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.Prognostic stratification of ulcerated melanoma: not only the extent matters.Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.Correction to: Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
P50
Q31057477-367E09A3-0D6D-4224-AF5B-D2A42B7C81B2Q34029313-D6564597-F1D2-4DB6-8D23-C827FDBE3E5FQ34358140-090D9072-0346-4891-A950-C02D74E54549Q34538761-E6857A4B-B3F8-4F7F-ABD2-9EB07A1978C2Q34732822-7A898FE9-EB93-4197-B201-F946A3C3CA2BQ35122854-64B5F607-1BC4-41DE-9082-BE3DF206DF04Q35364112-5801CA0D-87B5-4F50-839E-241AACEE0FC8Q36068221-030A1898-D2F1-4C1C-AEEB-587E9D23DFCCQ36142511-DDA91C24-EF66-4BBD-9334-35C7C5ACC200Q36387936-32EBFA26-FDBE-4B12-9951-8993E024F2A8Q36392530-3016B1C6-1F0B-42C2-9ECD-A4EFE9708566Q37014721-939A43C3-8D16-4250-87DA-5362750C7A9BQ37573795-20085855-84BB-47D1-8458-9C91A999BAC0Q37704756-B5381568-BD44-4811-B708-E51957995AFFQ38824039-7654D25E-9EB3-43B8-ADB5-D99890F2CFBCQ39106259-2C8CD375-5EF6-4224-A206-3C434E8CAAC2Q40016673-C4F970A3-DD72-44A2-AC5E-8B4D5149D98EQ40158777-B015C5D2-F733-40AF-8554-C13370EAE410Q40632660-B377B0D6-76BA-435D-8AF5-4A308D4E70D6Q40743206-E0E0B934-F8EB-46A1-BC10-2CF8045BF243Q40812649-E1E88DAB-35C3-4FB6-9F27-CCF2EBAF4051Q40889762-3B61B861-4E04-4FF6-8394-8C6B7F69790DQ41071756-2CAB5ACA-6C54-4E15-8B6A-85D45A3C1147Q41182006-636BF57C-B5D9-46DE-BF40-5EB6EE03AF60Q41219178-BC98AD0F-C9A3-48D1-892D-71D94AE2C0D8Q41863389-3E022E7D-870C-453C-903F-E33F1C0E8E36Q42231930-C587408F-1018-40E1-84CF-BB5D1F8EA97EQ42232930-D9FF4B00-A16B-465D-8F3E-3D2DACEC8B32Q42275739-7BCD96B4-D55D-4DFB-B24A-1580FA1F4AEAQ42284206-472C50BD-5BBB-4F9D-A53D-1DD15553B75BQ43256666-0381C3AB-69D6-43FF-84A5-4D97C84AC729Q43544546-FBA3FD49-B874-4BCD-96D4-F3979B32CD41Q43687490-8504A89F-1899-43C9-B98F-55C5661996E6Q43813493-F82AA20A-6325-42D7-B966-B39535C15C99Q43836926-7ABEE680-1C7C-4AC2-B14C-D9C789BEC8E7Q44318263-BBF5AC92-CEF4-4982-9C21-853F021D670AQ45078050-271EAE10-DF62-458D-AC83-B0413470F499Q47266129-061AFEC2-3E2E-4CC0-8E24-B9893B2939B7Q47331169-976DFF8E-E0FC-4DB8-B419-86A36364B256Q47362509-D7750D01-B035-4383-A51E-06CD13206161
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
H J Møller
@ast
H J Møller
@en
H J Møller
@es
H J Møller
@nl
type
label
H J Møller
@ast
H J Møller
@en
H J Møller
@es
H J Møller
@nl
prefLabel
H J Møller
@ast
H J Møller
@en
H J Møller
@es
H J Møller
@nl
P31
P496
0000-0001-7687-5995